Literature DB >> 27605668

Up-regulation of N-cadherin by Collagen I-activated Discoidin Domain Receptor 1 in Pancreatic Cancer Requires the Adaptor Molecule Shc1.

Huocong Huang1, Robert A Svoboda2, Audrey J Lazenby3, Jintana Saowapa2, Nina Chaika4, Ke Ding5, Margaret J Wheelock1,2,4, Keith R Johnson6,2,4,7.   

Abstract

Pancreatic ductal adenocarcinomas are highly malignant cancers characterized by extensive invasion into surrounding tissues, metastasis to distant organs, and a limited response to therapy. A main feature of pancreatic ductal adenocarcinomas is desmoplasia, which leads to extensive deposition of collagen I. We have demonstrated that collagen I can induce epithelial-mesenchymal transition (EMT) in pancreatic cancer cells. A hallmark of EMT is an increase in the expression of the mesenchymal cadherin N-cadherin. Previously we showed up-regulation of N-cadherin promotes tumor cell invasion and that collagen I-induced EMT is mediated by two collagen receptors, α2β1-integrin and discoidin domain receptor 1 (DDR1). DDR1 is a receptor-tyrosine kinase widely expressed during embryonic development and in many adult tissues and is also highly expressed in many different cancers. In the signaling pathway initiated by collagen, we have shown proline-rich tyrosine kinase 2 (Pyk2) is downstream of DDR1. In this study we found isoform b of DDR1 is responsible for collagen I-induced up-regulation of N-cadherin and tyrosine 513 of DDR1b is necessary. Knocking down Shc1, which binds to tyrosine 513 of DDR1b via its PTB (phosphotyrosine binding) domain, eliminates the up-regulation of N-cadherin. The signaling does not require a functional SH2 domain or the tyrosine residues commonly phosphorylated in Shc1 but is mediated by the interaction between a short segment of the central domain of Shc1 and the proline-rich region of Pyk2. Taken together, these data illustrate DDR1b, but not DDR1a, mediates collagen I-induced N-cadherin up-regulation, and Shc1 is involved in this process by coupling to both DDR1 and Pyk2.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  DDR1; N-cadherin; Pyk2; Shc1; collagen; epithelial-mesenchymal transition (EMT); pancreatic cancer; receptor-tyrosine kinase

Mesh:

Substances:

Year:  2016        PMID: 27605668      PMCID: PMC5087738          DOI: 10.1074/jbc.M116.740605

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  67 in total

Review 1.  Novel chemical genetic approaches to the discovery of signal transduction inhibitors.

Authors:  Kevan Shokat; Mark Velleca
Journal:  Drug Discov Today       Date:  2002-08-15       Impact factor: 7.851

Review 2.  Tumor-stroma interactions in pancreatic ductal adenocarcinoma.

Authors:  Daruka Mahadevan; Daniel D Von Hoff
Journal:  Mol Cancer Ther       Date:  2007-04-03       Impact factor: 6.261

3.  Phosphoinositide-3 kinase-Rac1-c-Jun NH2-terminal kinase signaling mediates collagen I-induced cell scattering and up-regulation of N-cadherin expression in mouse mammary epithelial cells.

Authors:  Yasushi Shintani; Margaret J Wheelock; Keith R Johnson
Journal:  Mol Biol Cell       Date:  2006-04-19       Impact factor: 4.138

4.  Opposite effects of the p52shc/p46shc and p66shc splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway.

Authors:  E Migliaccio; S Mele; A E Salcini; G Pelicci; K M Lai; G Superti-Furga; T Pawson; P P Di Fiore; L Lanfrancone; P G Pelicci
Journal:  EMBO J       Date:  1997-02-17       Impact factor: 11.598

5.  Identification of residues that control specific binding of the Shc phosphotyrosine-binding domain to phosphotyrosine sites.

Authors:  P van der Geer; S Wiley; G D Gish; V K Lai; R Stephens; M F White; D Kaplan; T Pawson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-06       Impact factor: 11.205

6.  The GST-BHMT assay reveals a distinct mechanism underlying proteasome inhibition-induced macroautophagy in mammalian cells.

Authors:  Yan-Ning Rui; Zhen Xu; Zhihua Chen; Sheng Zhang
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

7.  Identification of novel series of pyrazole and indole-urea based DFG-out PYK2 inhibitors.

Authors:  Samit K Bhattacharya; Gary E Aspnes; Scott W Bagley; Markus Boehm; Arthur D Brosius; Leonard Buckbinder; Jeanne S Chang; Joseph Dibrino; Heather Eng; Kosea S Frederick; David A Griffith; Matthew C Griffor; Cristiano R W Guimarães; Angel Guzman-Perez; Seungil Han; Amit S Kalgutkar; Jacquelyn Klug-McLeod; Carmen Garcia-Irizarry; Jianke Li; Blaise Lippa; David A Price; James A Southers; Daniel P Walker; Liuqing Wei; Jun Xiao; Michael P Zawistoski; Xumiao Zhao
Journal:  Bioorg Med Chem Lett       Date:  2012-10-16       Impact factor: 2.823

8.  ADH-1 suppresses N-cadherin-dependent pancreatic cancer progression.

Authors:  Yasushi Shintani; Yuri Fukumoto; Nina Chaika; Paul M Grandgenett; Michael A Hollingsworth; Margaret J Wheelock; Keith R Johnson
Journal:  Int J Cancer       Date:  2008-01-01       Impact factor: 7.396

9.  Anticancer Effects of Mesothelin-Targeted Immunotoxin Therapy Are Regulated by Tyrosine Kinase DDR1.

Authors:  Fatima Ali-Rahmani; David J FitzGerald; Scott Martin; Paresma Patel; Marco Prunotto; Pinar Ormanoglu; Craig Thomas; Ira Pastan
Journal:  Cancer Res       Date:  2015-12-30       Impact factor: 13.312

10.  PARP14 promotes the Warburg effect in hepatocellular carcinoma by inhibiting JNK1-dependent PKM2 phosphorylation and activation.

Authors:  Valeria Iansante; Pui Man Choy; Sze Wai Fung; Ying Liu; Jian-Guo Chai; Julian Dyson; Alberto Del Rio; Clive D'Santos; Roger Williams; Shilpa Chokshi; Robert A Anders; Concetta Bubici; Salvatore Papa
Journal:  Nat Commun       Date:  2015-08-10       Impact factor: 14.919

View more
  20 in total

Review 1.  Discoidin domain receptors: Micro insights into macro assemblies.

Authors:  Gunjan Agarwal; Adam W Smith; Blain Jones
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2019-06-21       Impact factor: 4.739

2.  Beyond Stiffness: Collagen Signaling in Pancreatic Cancer and Pancreas Regeneration.

Authors:  Huocong Huang; Rolf A Brekken
Journal:  Am J Pathol       Date:  2020-05-22       Impact factor: 4.307

Review 3.  Recent advances in understanding cancer-associated fibroblasts in pancreatic cancer.

Authors:  Huocong Huang; Rolf A Brekken
Journal:  Am J Physiol Cell Physiol       Date:  2020-05-20       Impact factor: 4.249

4.  Inhibition of Discoidin Domain Receptor 1 Reduces Collagen-mediated Tumorigenicity in Pancreatic Ductal Adenocarcinoma.

Authors:  Kristina Y Aguilera; Huocong Huang; Wenting Du; Moriah M Hagopian; Zhen Wang; Stefan Hinz; Tae Hyun Hwang; Huamin Wang; Jason B Fleming; Diego H Castrillon; Xiaomei Ren; Ke Ding; Rolf A Brekken
Journal:  Mol Cancer Ther       Date:  2017-09-01       Impact factor: 6.261

Review 5.  Upregulated N-cadherin expression is associated with poor prognosis in epithelial-derived solid tumours: A meta-analysis.

Authors:  Yong Luo; Ting Yu; Qiongwen Zhang; Qingyu Fu; Yuzhu Hu; Mengmeng Xiang; Haoning Peng; Tianying Zheng; Li Lu; Huashan Shi
Journal:  Eur J Clin Invest       Date:  2018-02-25       Impact factor: 4.686

Review 6.  Tumor organoid models in precision medicine and investigating cancer-stromal interactions.

Authors:  Ren Xu; Xiaotao Zhou; Shike Wang; Christine Trinkle
Journal:  Pharmacol Ther       Date:  2020-08-24       Impact factor: 12.310

7.  Western diet leads to aging-related tumorigenesis via activation of the inflammatory, UPR, and EMT pathways.

Authors:  Ricardo Imbroisi Filho; Alan C Ochioni; Amanda M Esteves; João G B Leandro; Thainá M Demaria; Mauro Sola-Penna; Patricia Zancan
Journal:  Cell Death Dis       Date:  2021-06-23       Impact factor: 8.469

Review 8.  Pancreatic cancer stroma: an update on therapeutic targeting strategies.

Authors:  Abdel N Hosein; Rolf A Brekken; Anirban Maitra
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-05-11       Impact factor: 73.082

Review 9.  Complex roles of the stroma in the intrinsic resistance to gemcitabine in pancreatic cancer: where we are and where we are going.

Authors:  Chen Liang; Si Shi; Qingcai Meng; Dingkong Liang; Shunrong Ji; Bo Zhang; Yi Qin; Jin Xu; Quanxing Ni; Xianjun Yu
Journal:  Exp Mol Med       Date:  2017-12-01       Impact factor: 8.718

10.  Overexpression of CCDC34 in colorectal cancer and its involvement in tumor growth, apoptosis and invasion.

Authors:  Wei Geng; Wei Liang; Yanan Fan; Zhibin Ye; Lixiao Zhang
Journal:  Mol Med Rep       Date:  2017-10-24       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.